Stocktoria
LENZ Therapeutics, Inc. LENZ
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-06-25
LENZ Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 960,044 | $16.6M | 3.06% |
| MILLENNIUM MANAGEMENT LLC | 1,508,478 | $8.6M | 4.81% |
| CITADEL ADVISORS LLC | 580,629 | $3.3M | 1.85% |
| TWO SIGMA INVESTMENTS, LP | 285,584 | $1.6M | 0.91% |
| AQR CAPITAL MANAGEMENT LLC | 227,732 | $1.3M | 0.73% |
| RENAISSANCE TECHNOLOGIES LLC | 70,628 | $401,167 | 0.23% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.